NCT03066570View on ClinicalTrials.gov

Graded Exposure in Patients With Painful Diabetic Neuropathy

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

March 18, 2019

Study Completion Date

March 18, 2019

Conditions
Painful Diabetic NeuropathyDiabetic Neuropathies, PainfulNeuralgia, Diabetic
Interventions
BEHAVIORAL

Graded Exposure

Graded Exposure in vivo (GEXP) is a second-generation cognitive-behavioural intervention, and is characterized by systematic and repeated exposure to feared movements, activities and/or sensations in order to decrease fear and subsequently increase physical activity.

Trial Locations (1)

6229HX

Maastricht University Medical Center, Maastricht

All Listed Sponsors
lead

Maastricht University Medical Center

OTHER

NCT03066570 - Graded Exposure in Patients With Painful Diabetic Neuropathy | Biotech Hunter | Biotech Hunter